AIT Therapeutics, Inc. (OTCMKTS:AITB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On February 12, 2017, Ms. Racheli Vizman, Chief Operating Officer of AIT Therapeutics, Inc., a Delaware corporation (the “Company”), delivered notice of her resignation to the Company, effective as of March 20, 2017. Ms. Vizman resigned to pursue new opportunities and not due to any disagreement with the Company.

About AIT Therapeutics, Inc. (OTCMKTS:AITB)
AIT Therapeutics, Inc., formerly KokiCare, Inc., is a shell company. The Company is engaged in the discovery and planning phase to develop a real-time, software as a service (SaaS)-based enterprise software application to manage the integration, planning, tracking and management of healthcare assets, which include people, supplies, clinical data, relationships and financial resources of healthcare organizations. The Company seeks to develop health care enterprise software to be sold to hospitals, medical centers and health care facilities in the United States and internationally. As of September 30, 2016, the Company had not generated any revenues. AIT Therapeutics, Inc. (OTCMKTS:AITB) Recent Trading Information
AIT Therapeutics, Inc. (OTCMKTS:AITB) closed its last trading session 00.00 at 30.00 with shares trading hands.